<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE us-patent-application SYSTEM "us-patent-application-v43-2012-12-04.dtd" [ ]><us-patent-application lang="EN" dtd-version="v4.3 2012-12-04" file="US20140005141A1-20140102.XML" status="PRODUCTION" id="us-patent-application" country="US" date-produced="20131218" date-publ="20140102"><us-bibliographic-data-application lang="EN" country="US"><publication-reference><document-id><country>US</country><doc-number>20140005141</doc-number><kind>A1</kind><date>20140102</date></document-id></publication-reference><application-reference appl-type="utility"><document-id><country>US</country><doc-number>14013454</doc-number><date>20130829</date></document-id></application-reference><us-application-series-code>14</us-application-series-code><classifications-ipcr><classification-ipcr><ipc-version-indicator><date>20060101</date></ipc-version-indicator><classification-level>A</classification-level><section>C</section><class>08</class><subclass>B</subclass><main-group>37</main-group><subgroup>08</subgroup><symbol-position>F</symbol-position><classification-value>I</classification-value><action-date><date>20140102</date></action-date><generating-office><country>US</country></generating-office><classification-status>B</classification-status><classification-data-source>H</classification-data-source></classification-ipcr></classifications-ipcr><classifications-cpc><main-cpc><classification-cpc><cpc-version-indicator><date>20130101</date></cpc-version-indicator><section>C</section><class>08</class><subclass>B</subclass><main-group>37</main-group><subgroup>0072</subgroup><symbol-position>F</symbol-position><classification-value>I</classification-value><action-date><date>20140102</date></action-date><generating-office><country>US</country></generating-office><classification-status>B</classification-status><classification-data-source>H</classification-data-source><scheme-origination-code>C</scheme-origination-code></classification-cpc></main-cpc></classifications-cpc><classification-national><country>US</country><main-classification>514 54</main-classification><further-classification>536 551</further-classification></classification-national><invention-title id="d0e43">HYDRAZIDO DERIVATIVES OF HYALURONIC ACID</invention-title><us-related-documents><continuation><relation><parent-doc><document-id><country>US</country><doc-number>12282129</doc-number><date>20090209</date></document-id><parent-grant-document><document-id><country>US</country><doc-number>8524885</doc-number></document-id></parent-grant-document><parent-pct-document><document-id><country>WO</country><doc-number>PCT/IL07/00284</doc-number><date>20070306</date></document-id></parent-pct-document></parent-doc><child-doc><document-id><country>US</country><doc-number>14013454</doc-number></document-id></child-doc></relation></continuation><us-provisional-application><document-id><country>US</country><doc-number>60779423</doc-number><date>20060307</date></document-id></us-provisional-application></us-related-documents><us-parties><us-applicants><us-applicant sequence="00" app-type="applicant" designation="us-only" applicant-authority-category="assignee"><addressbook><orgname>Bio-Technology General (Israel) Ltd.</orgname><address><city>Kiryat Malachi</city><country>IL</country></address></addressbook><residence><country>IL</country></residence></us-applicant><us-applicant sequence="01" app-type="applicant" designation="us-only" applicant-authority-category="assignee"><addressbook><orgname>Prochon Biotech Ltd.</orgname><address><city>Ness Ziona</city><country>IL</country></address></addressbook><residence><country>IL</country></residence></us-applicant></us-applicants><inventors><inventor sequence="00" designation="us-only"><addressbook><last-name>AMIT</last-name><first-name>Boaz</first-name><address><city>Kiron</city><country>IL</country></address></addressbook></inventor><inventor sequence="01" designation="us-only"><addressbook><last-name>Wortzel</last-name><first-name>Avraham</first-name><address><city>Rishon le Zion</city><country>IL</country></address></addressbook></inventor><inventor sequence="02" designation="us-only"><addressbook><last-name>YAYON</last-name><first-name>Avner</first-name><address><city>Moshav Sitria</city><country>IL</country></address></addressbook></inventor></inventors></us-parties><assignees><assignee><addressbook><orgname>Bio-Technology General (Israel) Ltd.</orgname><role>03</role><address><city>Kiryat Malachi</city><country>IL</country></address></addressbook></assignee><assignee><addressbook><orgname>Prochon Biotech Ltd.</orgname><role>03</role><address><city>Ness Ziona</city><country>IL</country></address></addressbook></assignee></assignees></us-bibliographic-data-application><abstract id="abstract"><p id="p-0001" num="0000">Disclosed are chemically modified hyaluronic acid (HA) derivatives containing hydrazido groups directly linked to the glucuronic acid residues of HA. Said hydrazido groups are used to obtain crosslinked and labeled HA derivatives. The invention further relates to methods of preparation of said HA derivatives.</p></abstract></us-patent-application>